RA Capital Management is a Boston-based investment firm specializing in healthcare, life sciences, and planetary health. It pursues evidence-based, science-led investing through its internal TechAtlas research engine and supports portfolio companies via its Raven healthcare incubator. The firm engages across stages from seed funding to IPOs and follow-on financings, focusing on drugs, medical devices, diagnostics, and other biomedical innovations, with a regional emphasis on the United States and Europe.

MassVentures is a Massachusetts-based venture capital firm focused on seed and early-stage investments that advance high-growth startups from concept to commercialization within the state’s innovation economy. Established in 1978 as a quasi-public entity by the Massachusetts Legislature and governed by an independent board, the firm funds ventures in deep tech and related sectors, including quantum computing, clean energy, biotech, artificial intelligence, advanced materials, manufacturing, and robotics. It has backed hundreds of companies and oversees more than $4 billion in follow-on capital, reflecting a durable track record of helping startups attract additional funding and scale. Beyond capital, MassVentures provides non-dilutive grants, commercialization support, mentorship, and strategic guidance through programs such as MV Capital and MV Accelerate, all aimed at building inclusive, connected ventures that leverage Massachusetts’ innovation ecosystem.

Morningside Group is a venture capital firm based in Newton, Massachusetts, founded in 1986 as a family office for the Chan family. It pursues long-term investments in companies with novel science and technology, with active interest in life sciences, digital health, artificial intelligence, materials, and technology sectors. The firm emphasizes ethical business practices and seeks to support the growth of enduring companies. Beyond its investing activities, Morningside supports education, research, and healthcare through charitable commitments to institutions such as the Harvard T.H. Chan School of Public Health, UMass Chan Medical School, and the MIT Morningside Academy for Design.

Atlas Venture is a Cambridge, Massachusetts-based venture capital firm that specializes in early-stage biotechnology and life sciences companies. Founded in 1980, it focuses on translating breakthrough science into medicines and medical technologies, often employing a seed-led venture creation approach and taking lead investor roles with board representation. The firm operates with dedicated Life Sciences and Technology teams and invests across the United States and Europe, supporting startups through initial funding and early growth. Its portfolio emphasizes biopharmaceuticals, diagnostics, medical devices, and related platforms, reflecting a commitment to advancing innovative healthcare solutions.

Alumni Ventures is a venture capital firm that invests in startups from seed through late-stage, including pre-IPO companies, and provides strategic capital and support to founders. It gives accredited investors access to diversified venture portfolios and co-investment opportunities, including investments in companies connected to alumni communities. The firm is based in Manchester, New Hampshire, and operates across North America, with additional offices in London and Tokyo.

General Catalyst is a venture capital firm headquartered in Cambridge, Massachusetts, with offices and investment activity across North America and Europe. It invests in companies from early to growth stages, with a focus on technology, healthcare, fintech, consumer businesses, and applied artificial intelligence, and provides founders with capital and strategic support.

ARCH Venture Partners is a venture capital firm founded in 1986 and based in Chicago, Illinois, with additional operations in Seattle. The firm focuses on science-based companies, prioritizing life sciences and related technologies, and aims to translate academic and national lab innovations into commercially viable products. ARCH emphasizes a true partnership approach, providing capital alongside strategic guidance, expertise, and a broad professional network to founders. It has supported numerous companies across early to growth stages and is known for backing translational efforts that bring breakthrough discoveries to market, leveraging collaborations with researchers and entrepreneurs to accelerate development of disruptive technologies on a national and international scale.

Flagship Pioneering is a Cambridge, Massachusetts-based venture creation company that conceives, builds, and resources first-in-category ventures aimed at transforming human health, biotechnology, and sustainability. Through an integrated approach that combines scientific discovery with entrepreneurial capital, it develops ideas from inception through company creation, supporting portfolio companies such as Moderna, Tessera Therapeutics, Generate Biomedicines, and Quotient Therapeutics. It pursues ambitious programs in biology, medicine, energy, and related fields, frequently collaborating with industry partners and institutions to accelerate discovery and development. The firm emphasizes fearless exploration and an evolutionary methodology to translate scientific breakthroughs into durable companies and impactful solutions for people and the planet.

OrbiMed is a global healthcare investment firm based in New York, founded in 1989. It manages capital across public and private markets, including private equity, venture and growth investments, and private credit, with structured debt and royalty arrangements to support owners of intellectual property and diagnostics. The firm focuses on biopharmaceuticals, life sciences, medical devices, diagnostics, health IT, and healthcare services, investing from startups to multinational companies. With a worldwide team and offices in multiple regions, OrbiMed provides financing and strategic resources to advance therapies and healthcare innovations, aiming to improve patient outcomes across global markets.

Mission BioCapital is a life science venture capital firm that backs early-stage biotechnology and life sciences companies. With leadership that has a long history of founding and supporting dozens of startups, the firm operates from Cambridge, Massachusetts and San Francisco, California, leveraging a network of researchers and venture capital partners. It provides mentorship, collaboration, and hands-on support from concept through clinical trials, including access to shared laboratory space through its Platinum Program, which offers up to $500,000 in funding, a lab bench, and related services for promising startups. The firm focuses on accelerating scientific solutions and actively participates in portfolio company growth across therapeutic areas, backing companies through multiple funds.

The Invus Group is a long-standing private equity firm founded in 1985 and based in New York. It partners with entrepreneurs to drive transformative growth across sectors including consumer products and services, technology, life sciences, software, and industrials. The firm emphasizes long-term collaboration, aligns incentives with management, and provides both capital and strategic advisory to help portfolio companies scale internationally. It maintains a global presence with offices in the United States, Europe, and Asia, and pursues flexible investment approaches through evergreen capital structures and co-investment opportunities. The group supports management-led buyouts, growth equity, and select opportunistic investments, aiming to create lasting value rather than short-term gains.

New Enterprise Associates is a venture capital firm headquartered in Menlo Park, California. Founded in 1977, it invests in technology and healthcare companies from seed stage through later growth and public offerings, and provides founders with operational and strategic support. Its investments span areas including software, consumer technology, life sciences, biotechnology, medical devices, and energy technology. The firm operates across the United States, Asia, and Brazil, with offices in the United States, India, and China.

Hyperplane Venture Capital is a Boston-based early-stage venture capital firm that backs technology companies, with a focus on machine intelligence, data, and related technologies. The firm invests in early-stage startups across sectors including artificial intelligence and machine learning, distributed systems, automation, cloud computing, ambient intelligence, robotics, virtual reality, and augmented reality, partnering with exceptional founders who leverage machine intelligence, sensor technology, and cloud computing to solve complex problems and create solutions at the intersection of perception, communication, intelligence, and insight. It was founded in 2015 by Vivjan Myrto, John Murphy, and Brendan Kohler.

Founder Collective is a seed-stage venture capital firm focused on technology startups. Founded in 2009 by entrepreneurs who have built and exited technology companies, it emphasizes founder-aligned partnerships and capital efficiency, aiming to minimize dilution while supporting portfolio companies from idea to IPO. The firm takes a technology-centric, stage-agnostic approach within seed and early stages and makes investments across the United States and worldwide. Headquartered in Cambridge, Massachusetts, with an office in New York City, Founder Collective leverages the experience of its founders to provide hands-on guidance to portfolio companies. It is built by a collection of successful entrepreneurs and concentrates on backing ambitious teams with potential to reshape industries, prioritizing authenticity, long-term value creation, and close collaboration with founders.

Founded in 2007, Third Rock Ventures is a venture capital firm that invests in and helps build early-stage life sciences and healthcare companies, including businesses developing medicines, medical devices, diagnostics, and related technologies. It focuses on companies with potential to advance patient care and operates primarily in the United States. The firm is headquartered in Boston, Massachusetts, with an additional office in San Francisco, California.

Accomplice is a seed- and early-stage venture capital firm based in Boston/Cambridge, Massachusetts, backing technology startups in cybersecurity, esports, data analytics, SMB software, emerging hardware, and marketplaces. It operates a community-driven investment model using platforms such as AngelList, Boston Syndicates, Maiden Lane, Spearhead, BOSS, Rev, and TUGG to connect and support founders. Most investments are in Boston, with activity across the United States, Canada, and Europe. The firm originated as the technology group of Atlas Venture and, in 2014, split to form Accomplice, maintaining its focus on early-stage technology companies in New England.

Spark Capital is a venture capital firm founded in 2005 and based in San Francisco, with additional offices in Boston and New York. It invests across sectors including consumer, software, fintech, media, internet, education technology, and mobile, backing both early-stage and growth-stage startups. The firm is known for a founder-focused approach that emphasizes flexibility over rigid playbooks, supporting teams as they build and scale innovative products. Its portfolio includes high-profile companies such as Twitter, Discord, Oculus, Warby Parker, Niantic, and Tumblr, reflecting a history of backing companies at pivotal moments in technology and consumer markets.

Casdin Capital is a New York-based venture capital and investment firm focused on the life sciences and healthcare sectors. Founded in 2012 by Eli Casdin, the firm backs companies across genomic research, molecular medicine, precision medicine, diagnostics, synthetic biology, oncology, digital health, and related technologies. It pursues a data-driven, long-term investment approach and seeks to form strong partnerships with portfolio companies to advance scientific innovation and improve patient outcomes. The firm engages with ventures at various stages, from early- to late-stage private companies, emphasizing opportunities at the intersection of biology and technology. Through its activity in life sciences and healthcare, Casdin Capital positions itself as a partner to founders pursuing breakthroughs in genomics, molecular medicine, and AI-enabled healthcare platforms.

Beacon Angels is a Boston-based angel investment group founded in 2006 that funds early-stage, high-growth companies in New England. The group typically invests in the range of tens of thousands to a few hundred thousand dollars per company and conducts regular screening of opportunities, with monthly meetings for accredited members and scheduled reviews of new ventures, aiming to grow portfolio value through shared capital and strategic relationships.

MPM BioImpact is a biotechnology investment firm that builds and backs companies developing medicines for serious diseases. It invests across company stages, from early-stage startups to public companies, and provides scientific, clinical development, and company-building expertise. The firm is headquartered in Boston, Massachusetts, with an office in Brisbane, California, and invests in the United States, Europe, and Asia.

SOSV is a global venture capital firm focused on early-stage deep-tech and cross-border software companies, investing primarily from pre-seed through growth stages. It accelerates product development, regulatory progress, fundraising, and commercial strategy by providing founders access to purpose-built labs, engineering spaces, and a broad physical and virtual infrastructure across multiple locations. The firm's program-driven approach combines selective funding with hands-on support, mentorship, and a wide network of co-investors and partners to help portfolio companies scale. SOSV operates a suite of specialized facilities for deep-tech founders, including incubation programs that connect startups with customers, researchers, and investors, and it emphasizes long-term relationships through ongoing operational and strategic assistance. While active globally, it maintains strong ties to Asia-focused cross-border markets and supports a diverse portfolio spanning bio-tech, hardware, robotics, software, and related fields.

Khosla Ventures is a California-based venture capital firm founded in 2004 that backs technology-driven startups across multiple sectors, including artificial intelligence, healthcare, sustainability, digital health, and consumer technology. The firm provides capital and strategic guidance to companies at early and growth stages, with an emphasis on disruptive technologies and world-changing businesses. It operates a range of funds, including seed and later-stage vehicles, and maintains a broad investment thesis that covers AI, climate tech, energy efficiency, and other high-potential areas, primarily focused in the United States. The firm is known for working closely with entrepreneurs to build long-lasting companies.

.406 Ventures is a Boston-based early-stage venture capital firm that invests in enterprise information technology, cybersecurity, data and cloud, and technology-enabled software and services companies. Founded in 2005, the firm seeks to back B2B and healthcare-related technology sectors, including SaaS, AI, fintech, and digital health, often taking the lead as the first institutional investor in seed and de novo rounds. Investments typically range from $2 million to $5 million initially, with total commitments around $6 million to $10 million per company, and the firm aims to hold board seats as a lead investor. The team emphasizes hands-on involvement, leveraging practical industry experience and networks to help portfolio companies scale. It pursues opportunities across the United States, with emphasis on information technology security and infrastructure and other next-generation software and services.

E14 Fund is a venture capital firm based in Cambridge, Massachusetts, specializing in early-stage investments inspired by technologies developed at MIT. The firm supports seed to Series A rounds across deep technology sectors, helping entrepreneurs translate laboratory research into commercial products. Through a broad network of advisors, including investors, industry experts, and entrepreneurs, E14 Fund assists portfolio companies in scaling, attracting follow-on funding, and navigating market validation. The firm emphasizes diversity and inclusion as drivers of innovation and seeks to connect founders with researchers, mentors, and partners to accelerate development across fields such as biotechnology, smart cities, consumer electronics, and manufacturing.

Launchpad Venture Group is a Boston-based angel investment group that provides funding and strategic guidance to early-stage science and technology startups, primarily in New England. Established in 2001, it operates as a network of individual angel investors and has invested more than $125 million in over 150 startups. The group offers both financial capital and mentorship to help entrepreneurs build long-term value, positioning itself as a leading seed investor in the region across sectors including software, hardware, life sciences, and clean tech. It emphasizes active involvement, advisory support, and building lasting relationships with founders, and it is a member of the Angel Capital Association.

Safar Partners is a venture capital firm based in Cambridge, Massachusetts, investing in seed- to growth-stage technology companies. The firm sources opportunities through close ties with leading universities such as MIT, Harvard, and the University of Rochester and supports portfolio companies across their lifecycle. It focuses on platform technologies in cleantech and advanced materials, artificial intelligence and information technology, robotics, and life sciences including medical devices, primarily backing United States–based startups at early and growth stages.

Founded in 1970, CRV is a venture capital firm that invests in early-stage companies, primarily from seed through Series B. It backs startups in technology, enterprise, consumer, and healthcare and life sciences, and provides hands-on support to founders as they build their businesses. CRV has invested in more than 750 startups. Headquartered in Palo Alto, California, it also has an office in Cambridge, Massachusetts, and invests across North America.

Northpond Ventures is a science-driven venture capital firm based in Bethesda, Maryland, with offices in San Francisco and Cambridge. It focuses on life sciences, digital health, health tech, and adjacent technology sectors, including diagnostics, therapeutics, artificial intelligence, and machine learning. The firm backs science-based companies across development stages, providing capital and strategic support to enable growth and commercial success.

EcoR1 Capital is a venture capital firm based in San Francisco that invests in early-stage biotechnology companies developing innovative therapeutics. It applies a scientific approach, leveraging advances in molecular biology to identify promising ventures and support their pursuit of new medicines. The firm emphasizes partnering with entrepreneurs dedicated to therapeutic innovation and provides strategic and scientific guidance to help translate breakthrough discoveries into treatments for patients.

Tiger Global Management is a global investment firm founded in 2001 by Charles (Chase) Coleman. It invests in both private and public markets worldwide, with a focus on technology, internet, consumer, and financial services companies. The firm employs strategies across public equities, including growth and long/short approaches, and private investments across early to late stages, seeking high-quality growth opportunities throughout the lifecycle of portfolio companies. Its activities span globally, aiming to back innovative companies across diverse regions and industries. As a registered investment adviser in the United States, Tiger Global conducts its business through its own platform, dedicating capital to long-term partnerships with high-potential companies.

Bantam Group is an advisory and investment firm based in Westwood, Massachusetts, founded in 1993 by Joe Caruso. It works with entrepreneurs across industries, providing strategic guidance, mentorship, and advocacy, and acts as a catalyst for growth. The firm oversees a portfolio of affiliated companies and concentrates on the technology sector, offering support in funding, strategy, and leadership through its network and objective advice. Notable involvements include startups such as ZipCar, HubSpot, and Coffee Connection, which illustrate its hands-on approach to helping entrepreneurs realize their business goals.

Glasswing Ventures is a Boston-based venture capital firm founded in 2016 that focuses on early-stage investments in artificial intelligence, frontier technologies, and cybersecurity for enterprise use. The firm backs startups developing AI software, intelligent enterprise solutions, and security technologies, primarily in the United States with a concentration on the East Coast. It emphasizes deep technical expertise and provides advisory support and resources to portfolio companies to help them scale and realize value. Glasswing operates as a traditional VC, funding pre-seed and seed rounds and partnering with founders to transform markets through AI-driven innovation.

Longwood Fund is a venture capital firm based in Boston, Massachusetts, founded in 2010, focused on life sciences and healthcare. It invests in science-based companies that develop novel solutions for medical problems, primarily in biotechnology, pharmaceuticals, and related areas. The firm supports its portfolio from early-stage evaluation through clinical development and commercialization, leveraging a network of industry experts. Longwood highlights a track record of bringing therapies to patients, with more than 20 marketed products and roughly 25 therapies in late-stage development.

Omega Funds is a Boston-based venture capital firm founded in 2004 that focuses on investing in life sciences and related technologies. The firm targets opportunities in healthcare and biotech, including digital health, immunology, rare diseases, precision medicine, oncology, cybersecurity, and software-as-a-service, with activity across North America and Western Europe. Omega Funds acts as a registered investment adviser, supporting early-stage and growth companies as they develop therapeutic and digital health solutions.

Vivo Capital is a healthcare investment firm founded in 1996 and headquartered in Palo Alto, California, with offices in Beijing, Shanghai, Hong Kong, and Taipei. It invests in healthcare and life sciences companies across the United States, China, and other global markets, including biotechnology, pharmaceuticals, medical devices, and healthcare services. Its investment activities span venture capital, growth equity, private equity, and public equity.

Pillar VC is a Boston-based venture capital firm focused on seed and early-stage technology companies, including healthcare, biotechnology, artificial intelligence, and scientific discovery. The firm partners with technically driven founders from inception, applying a lab-to-launch playbook to turn research into market-leading companies. Its portfolio includes Abridge, Videa Health, PathAI, Neural Magic, Latent Labs, and Edison, among others, reflecting a commitment to healthcare outcomes, computing and enterprise intelligence, and innovative discovery approaches. Pillar VC backs more than 90 companies, with many originating from university research.

Founded in 1972 and headquartered in Menlo Park, California, Sequoia Capital is a venture capital firm that invests in companies from seed through growth stages. It focuses primarily on technology businesses across sectors including software, healthcare, financial services, energy, media, and consumer markets. The firm works with founders on product development, company building, and expansion. Its investment activity has covered the United States, China, India, and Israel.

Boston Seed Capital is a Boston-headquartered venture capital firm that focuses on seed and early-stage investments in internet-enabled and technology-driven companies across the United States. The firm backs startups in consumer, B2B software as a service, and related services sectors, including information technology, cybersecurity, e-commerce, big data, marketplaces, esports, artificial intelligence and machine learning. It maintains a presence in Wellesley Hills, Massachusetts, and supports founders from pre-seed to scale, leveraging the Boston innovation ecosystem to help accelerate growth.

Boston Harbor Angels is a Boston-based group of seasoned business leaders that invests in high-growth, early-stage companies. Founded in 2004, the group provides capital and hands-on guidance, drawing on expertise in life sciences, information technology, consumer products, fintech, healthcare, and related sectors. They typically participate in rounds of about 250,000 to 1.5 million, funding a portion of the round and syndicating with other angel groups or venture funds. Companies backed are expected to be close to commercialization with a defensible competitive edge and strong capital efficiency, able to reach profitability with less than five million dollars of equity investment and to generate at least a tenfold return within five years. Investments are made by individuals rather than a pooled fund, though members collaborate on due diligence and may act as lead or follow-on investors, particularly in life sciences. The group operates a structured screening process and is guided by a managing director, with a track record of mentorship, networking, and support for portfolio companies.

Founded in 2009 and headquartered in Menlo Park, California, Andreessen Horowitz is a venture capital firm that invests in technology companies from seed to growth stages. Its areas of focus include artificial intelligence, biotechnology and health, consumer technology, cryptocurrency, enterprise software, financial technology, infrastructure, gaming, and American innovation. The firm also supports portfolio companies by connecting them with technical advisors, experienced executives, and industry operators.

Boxer Capital is a biotech investment firm and the corporate venture capital arm of Tavistock Group, based in San Diego, California. The firm invests in biotechnology and precision medicine companies across private and public markets, spanning the drug development lifecycle from early discovery to late-stage development and commercialization, with a focus on oncology and novel targets. It emphasizes scientific expertise and a disciplined, research-driven due diligence process that includes clinical, regulatory, and commercial assessment. Boxer Capital maintains independent investment decisions and has partnered with portfolio companies such as Mirati Therapeutics to support growth. The firm seeks opportunities in specialized medicine, precision oncology, and related life sciences sectors.

Anterra Capital is an Amsterdam-headquartered investment firm focused on transforming the global food system through technology. It backs startups across the entire food value chain—from farming and agro inputs to logistics and consumer safety—prioritizing companies that commercialize novel technologies and services with potential for sustainability, safety, and efficiency gains. As a lead investor, Anterra takes significant minority equity positions and works actively with portfolio companies, often joining boards to help build lasting value. Typical investments range from EUR 1 million to EUR 15 million per company, with a track record of supporting subsequent rounds and facilitating access to additional capital. The firm pursues a long-term partnership approach, collaborating with management teams to accelerate growth and measure impact. Founded in 2013, Anterra operates from Amsterdam with a presence in Boston, and targets opportunities in Europe and North America, backed by strategic investors including Rabobank and Novo Holdings. The firm emphasizes governance, measurable outcomes, and ecosystem building to advance safe, sustainable, and efficient food systems.

5AM Ventures is a venture capital firm founded in 2002 that invests in early-stage companies in biopharmaceuticals, life sciences, healthcare, medical technology, and research instruments. Headquartered in San Francisco, it also has an office in Boston and invests in companies across the United States.

Arkin Bio Ventures is an investment firm focused on companies developing pharmaceutical, biotechnology, and medical device technologies. It is based in Herzliya, Israel, and invests in Israel and international markets, including North America and Europe.

Logos Capital is a biotechnology investment firm based in San Francisco, founded in 2019. It uses a disciplined, data-driven approach that combines in-house analytics with scientific and clinical expertise to identify transformative therapeutics. The firm conducts rigorous fundamental research across clinical, regulatory, operational, and commercial dimensions of drug development, leveraging a proprietary data science platform called Logos Analytics to assess clinical success probability. With an emphasis on risk management, Logos Capital aims to deliver long-term, uncorrelated returns through thorough due diligence and a holistic view of asset value.

Venrock is a venture capital firm founded in 1969 as the venture capital arm of the Rockefeller family. It concentrates on seed and first-round investments in technology and healthcare, with a broad remit across information technology, life sciences, media, energy, and emerging tech. The firm backs early- and growth-stage companies and has supported a number of notable portfolio companies, including Apple Computer, Intel, Illumina, Gilead Sciences, Endeca, Imperva, DoubleClick, Athenahealth, Centocor, Check Point Software, Nest, SlideShare, and Tudou. Venrock emphasizes partnering with entrepreneurs to build enduring companies and leverages its long history in technology and healthcare to help founders navigate growth, strategy, and complex markets.

Right Side Capital Management is a San Francisco-based venture capital firm that employs a quantitative, data-driven approach to fund technology startups at the earliest stages. Founded in 2012, it concentrates on capital-efficient companies that are generating revenue and typically seeks rounds of 50,000 to 500,000 dollars, often outside the traditional SF Bay Area and NYC hubs. The firm targets pre-product-market fit ventures across the United States and Canada, making a high volume of investments—hundreds of portfolio companies and more than two thousand investments since inception—with a philosophy of rapid, transparent decision-making and broad post-investment engagement. Its team leverages extensive operational experience to provide hands-on mentorship in areas such as sales, marketing, fundraising, and operations, aiming to support startups through critical growth phases and facilitate later-stage partnerships. RSCM positions itself as an operating-style fund focused on supporting founders, not a standard VC, and emphasizes building a diverse, founder-focused community through events and guidance.

Data Point Capital is a Boston-based venture capital firm founded in 2012 that invests in technology companies across sectors such as e-commerce, mobile, media, cloud-based enterprise software, and the industrial internet of things. It operates on a non-stage-specific basis and emphasizes a data-driven, capital-efficient approach, partnering closely with founders to accelerate growth and pursue exits. Comprised of former operators and internet executives, the firm aims to add value beyond capital by applying hands-on expertise to scaling businesses from startup to growth stage.

Deep Track Capital is a venture capital firm headquartered in Greenwich, Connecticut. Founded in 2020, it concentrates on the life sciences and biotechnology sectors, investing in public and pre-IPO biotechnology companies. The firm emphasizes a hands-on partnership approach, providing capital, scientific expertise, and an extensive network to management teams. It seeks to lead transactions, form large syndicates, and participate in rounds led by other qualified investors, aiming to accelerate the development and commercialization of innovative biotech ventures.

Flare Capital Partners is a Boston-based venture capital firm founded in 2013 that invests in healthcare technology and related sectors. It targets early-stage companies, primarily seed and Series A rounds, that aim to improve clinical outcomes and reduce costs, including healthtech software, data analytics, artificial intelligence, and medical devices. The firm invests across the United States, partnering with founders to scale solutions that enable value-based care and data-driven healthcare. It maintains a network of senior healthcare executives and an AI advisory council to support portfolio companies advancing AI-powered innovation. The firm also supports the next generation of healthcare leaders through initiatives like the Flare Scholars Program. In summary, Flare Capital Partners focuses on early-stage, transformational healthcare technologies that leverage software, data, and AI to improve outcomes and efficiency.